Category: Therapeutic Area
Global Therapeutic Area
-
Global Anticoagulant Reversal Drugs Databank Market Report
... 2023 to 2031. Idarucizumab segment is expected to be the highest contributor to this market, with $288.6 Million in 2022, and is anticipated to reach $799.0 Million by 2031, registering a CAGR of 12.05%. Phytonadione ... Read More
-
Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents, Equipment), Type (Custom, Predesigned), Application (Therapeutic (Neurology, Rare), Research (PCR, Sequencing), Diagnostics) - Global Forecast to 2029
... to reach USD 19.7 billion by 2029 from USD 8.8 billion in 2024, at a CAGR of 17.5% during the forecast period. The synthesized oligonucleotide market is projected to reach USD 4.9 billion in 2029 ... Read More
-
Global Myopia And Presbyopia Treatment Databank Market Report
... 8.97% from 2023 to 2031. Contact Lenses segment is expected to be the highest contributor to this market, with $10,024.4 Million in 2022, and is anticipated to reach $22,511.1 Million by 2031, registering a CAGR ... Read More
-
Global Cancer Supportive Care Drugs Databank Market Report
... 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of ... Read More
-
Global Food Allergy Diagnostics & Therapeutics Databank Market Report
... CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to be the highest contributor to this market, with $2,241.8 Million in 2022, and is anticipated to reach $3,594.6 Million by 2031, registering ... Read More
-
Global Stomach Cancer Treatment Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More
-
Global Next Generation Cancer Diagnostics Databank Market Report
... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More
-
Global Anti-Cancer Drug Databank Market Report
... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More
-
Global Anterior Uveitis Treatment Databank Market Report
... 2023 to 2031. Corticosteroids segment is expected to be the highest contributor to this market, with $97.0 Million in 2022, and is anticipated to reach $125.8 Million by 2031, registering a CAGR of 2.97%. Anti-TNF ... Read More
-
Global Antacids Databank Market Report
... segment is expected to be the highest contributor to this market, with $4,872.4 Million in 2022, and is anticipated to reach $6,411.1 Million by 2031, registering a CAGR of 3.14%. Liquid segment is anticipated to ... Read More
-
Global Squalene Databank Market Report
... segment is expected to be the highest contributor to this market, with $64.7 Million in 2022, and is anticipated to reach $147.9 Million by 2031, registering a CAGR of 9.69%. Plants segment is anticipated to ... Read More
-
Global Encephalitis Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be ... Read More
-
Global Dermatology Diagnostics Devices Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... global Dermatology Diagnostics Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & ... Read More
-
Global Hospital Acquired Infections Therapeutic Databank Market Report
... 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR ... Read More
-
Global Pediatric Imaging Databank Market Report
... 2031. Magnetic Resonance Imaging segment is expected to be the highest contributor to this market, with $3,058.4 Million in 2022, and is anticipated to reach $5,133.5 Million by 2031, registering a CAGR of 5.97%. X-ray ... Read More
-
Global Urology Surgical Instruments Databank Market Report
... 2021 to 2029. Endoscopes segment is expected to be the highest contributor to this market, with $4,160.0 Million in 2020, and is anticipated to reach $6,777.1 Million by 2029, registering a CAGR of 5.61%. Envision ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Metabolic Testing Databank Market Report
... 2029. Body Composition Analyzers segment is expected to be the highest contributor to this market, with $256.7 Million in 2020, and is anticipated to reach $394.6 Million by 2029, registering a CAGR of 4.94%. Body ... Read More
-
Global Skin Boosters Databank Market Report
... 2031. Mesotherapy segment is expected to be the highest contributor to this market, with $543.3 Million in 2022, and is anticipated to reach $1,044.1 Million by 2031, registering a CAGR of 7.58%. Micro-needle segment is ... Read More
-
Global Acute Coronary Syndrome Therapeutic Databank Market Report
... 4.44% from 2023 to 2031. Non-St-Elevation Myocardial Infarction segment is expected to be the highest contributor to this market, with $3,528.2 Million in 2022, and is anticipated to reach $4,904.8 Million by 2031, registering a ... Read More
-
Global Periodontal Scalers And Curettes Databank Market Report
... 7.50% from 2021 to 2029. Curved segment is expected to be the highest contributor to this market, with $9,385.5 Million in 2020, and is anticipated to reach $17,484.7 Million by 2029, registering a CAGR of ... Read More
-
Global Brain Cancer Diagnostics Databank Market Report
... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Breast Pump Databank Market Report
... 2031. Open System segment is expected to be the highest contributor to this market, with $1,771.7 Million in 2022, and is anticipated to reach $3,121.8 Million by 2031, registering a CAGR of 6.54%. Closed System ... Read More
Research Assistance
